TITLE

James Edgar Lundeen, Sr., M.D.; Dismissal of Proceeding

AUTHOR(S)
Leonhart, Michele M.
PUB. DATE
May 2012
SOURCE
Federal Register (National Archives & Records Service, Office of;5/18/2012, Vol. 77 Issue 97, p29696
SOURCE TYPE
Government Documents
DOC. TYPE
Article
ABSTRACT
The article presents information on an order to show cause issued by the U.S. Drug Enforcement Administration of the U.S. Department of Justice to James Edgar Lundeen, a medical professional, regarding an authorization for dispensing controlled substances in Ohio.
ACCESSION #
76112123

 

Related Articles

  • DEPARTMENT OF JUSTICE.  // Federal Register (National Archives & Records Service, Office of;11/9/2012, Vol. 77 Issue 218, p67396 

    The article presents updates on the rules or proposed rules by the U.S. Department of Justice as of November 2012. A notice of application was issued by the Drug Enforcement Administration for Fisher Clinical Services, Inc. as importer of controlled substances. The notice is pursuant to Title 21...

  • DEA aims to limit use of obesity drug. Wilson, Megan R. // Hill;12/20/2012, Vol. 19 Issue 145, p7 

    The article reports on the proposal of the U.S. Drug Enforcement Agency (DEA) to classify the obesity drug Lorcaserin as a controlled substance.

  • Classification of Two Steroids, Prostanozol and Methasterone, as Schedule III Anabolic Steroids Under the Controlled Substances Act. Leonhart, Michele M. // Federal Register (National Archives & Records Service, Office of;7/30/2012, Vol. 77 Issue 146, p44456 

    The article presents the issuance of the final rule by the administrator of the Drug Enforcement Administration (DEA) in the U.S. in 2012. The final rule categorizes methasterone and prostanozol as anabolic steroids under the Controlled Substances Act (CSA). It mentions that methasterone and...

  • Importer of Controlled Substances; Notice of Application Meridian Medical Technologies. Rannazzisi, Joseph T. // Federal Register (National Archives & Records Service, Office of;4/2/2012, Vol. 77 Issue 63, p19716 

    The article presents information on an application filed by Meridian Medical Technologies Inc. to the U.S. Drug Enforcement Administration to get registration for importing morphine, a basic class of controlled substance.

  • Importer of Controlled Substances; Notice of Registration Mallinckrodt LLC. Rannazzisi, Joseph T. // Federal Register (National Archives & Records Service, Office of;4/2/2012, Vol. 77 Issue 63, p19717 

    The article presents information on an application filed by Mallinckrodt Inc. to the U.S. Drug Enforcement Administration to get registration for importing controlled substances including phenylacetone, coca leaves and opium.

  • Manufacturer of Controlled Substances; Notice of Application; Cerilliant Corporation. Rannazzisi, Joseph T. // Federal Register (National Archives & Records Service, Office of;4/2/2012, Vol. 77 Issue 63, p19717 

    The article presents information on an application filed by Cerilliant Corp. to the U.S. Drug Enforcement Administration to get registration for bulk manufacturer of controlled substances including 4-methyl-N-methylcathinone, 3,4-methylenedioxypyrovalerone and desomorphine.

  • Manufacturer of Controlled Substances; Notice of Registration, Norac Inc. Rannazzisi, Joseph T. // Federal Register (National Archives & Records Service, Office of;4/2/2012, Vol. 77 Issue 63, p19718 

    The article presents information on an application filed by Norac Inc. to the U.S. Drug Enforcement Administration to get registration for bulk manufacturer of controlled substances including Tetrahydrocannabinols, Pentobarbital and Nabilone.

  • Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Proposed Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2013. Harrigan, Thomas M. // Federal Register (National Archives & Records Service, Office of;8/3/2012, Vol. 77 Issue 150, p46519 

    The article presents a notice and request for comments from the Drug Enforcement Administration (DEA) of the U.S. Department of Justice (DOJ) on the proposed aggregate production quotas and assessment of controlled substances. The DEA proposes the 2013 aggregate production quotas for controlled...

  • Manufacturer of Controlled Substances; Notice of Application; Lipomed. Rannazzisi, Joseph T. // Federal Register (National Archives & Records Service, Office of;8/7/2012, Vol. 77 Issue 152, p47108 

    The article announces a notice from the U.S. Drug Enforcement Administration of the Department of Justice concerning an application filed by Lipomed Inc. as an importer of several basic classes of controlled substances.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics